The current valuation score of Beyondspring Inc is 8.39, ranking 132 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.82, which is -90.31% below the recent high of -0.95 and -1574.09% above the recent low of -164.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.